Back

Association between cytomegalovirus infection and cardiac allograft vasculopathy in heart transplant recipients: a single-center retrospective cohort study

30 August 2026 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Heart transplantation: fibrosis scores and quality of life Heart Transplantation ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Nawaf Alshehri

King Faisal Specialist Hospital and Research Centre (Gen. Org.), Riyadh (Saudi Arabia)

5 More presentations in this session

Presentation thumbnail
Primary graft dysfunction after LVAD bridge-to-transplant: a systematic review and meta-analysis
Mr T. Phatinavin (Bangkok, TH)
Abstract Slides
Presentation thumbnail
Bridge to transplant in the contemporary allocation era: a systematic review and meta-analysis of impella versus intra-aortic balloon pump
Doctor J. Giorgi (Sao Paulo, BR)
Abstract Slides
Presentation thumbnail
Periodic repolarization dynamics and deceleration capacity in heart transplant recipients
Mrs B. Knap (Innsbruck, AT)
Abstract Slides Video
Presentation thumbnail
Effect of a nurse-led multidisciplinary programme on quality of life, anxiety and depression in heart failure.
Mrs M. Kyriakou (Nicosia, CY)
Abstract Slides Video
Presentation thumbnail
SGLT2 inhibitors and health-related quality of life in heart failure: a systematic review and meta-analysis
Doctor C. Di Lorenzo (Naples, IT)
Abstract Slides

Access the full session

Session thumbnail
Heart transplantation: fibrosis scores and quality of life

The Event

Event poster

ESC Congress 2026

30 August 2026 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Modern post-transplant surveillance: acute rejection and cardiac allograft vasculopathy
18 May 2025
thumbnail
Congress Presentation
Latent cytomegalovirus infection associates with impairments in myocardial reperfusion, left-ventricular function, and quality of life after ST-elevation myocardial infarction
30 August 2024
thumbnail
Congress Presentation
Long-term outcomes of heart re-transplantation from HCV-viremic donors based on UNOS registry
1 September 2024
thumbnail
Congress Presentation
Everolimus-based immunosuppression in heart transplantation reduces cardiac allograft vasculopathy progression and preserves renal function: a systematic review and meta-analysis
30 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources